WINTON GROUP Ltd Takes $270,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

WINTON GROUP Ltd acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 901 shares of the company’s stock, valued at approximately $270,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. MML Investors Services LLC raised its stake in shares of HCA Healthcare by 31.7% in the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after purchasing an additional 4,285 shares during the last quarter. Meritage Group LP purchased a new position in HCA Healthcare during the 3rd quarter worth $150,548,000. Galvin Gaustad & Stein LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at about $18,044,000. NRI Wealth Management LC purchased a new position in HCA Healthcare during the fourth quarter worth about $2,896,000. Finally, Czech National Bank lifted its position in shares of HCA Healthcare by 4.5% during the 4th quarter. Czech National Bank now owns 39,543 shares of the company’s stock worth $11,869,000 after buying an additional 1,691 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

HCA stock opened at $342.25 on Monday. The firm has a 50 day simple moving average of $324.53 and a two-hundred day simple moving average of $340.92. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The stock has a market cap of $84.26 billion, a PE ratio of 15.58, a P/E/G ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the business earned $5.90 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.84%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on HCA shares. Royal Bank of Canada reduced their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Truist Financial decreased their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. KeyCorp cut their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Finally, Barclays cut their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.